AYTU BioPharma
  • About
    • Overview
    • Our Mission, Vision & Values
    • Leadership
    • Governance & Compliance
    • Partnering
    • Contact
  • Products
    • Overview
    • EXXUA™
    • ADHD Portfolio
    • Legacy Portfolio
  • Partnering
  • RxConnect
  • News
Investors | Careers | +1 (855) AYTU BIO (+1 855-298-8246)
Contact Us
AYTU BioPharma logo
Investors | Careers | +1 (855) AYTU BIO (+1 855-298-8246)
AYTU BioPharma logo
  • About
    • Overview
    • Our Mission, Vision & Values
    • Leadership
    • Governance & Compliance
    • Partnering
    • Contact
  • Products
    • Overview
    • EXXUA™
    • ADHD Portfolio
    • Legacy Portfolio
  • Partnering
  • RxConnect
  • News
Contact Us

Analyst Coverage

☰  IR MENU
  • Overview
  • Press Releases
  • SEC Filings
  • Stock Info
    • Stock Quote & Chart
    • Analyst Coverage
  • Events & Presentations
  • Governance
    • Governance Documents
    • Leadership
  • Resources
    • Investor FAQs
    • IR Contacts
    • Investor Alerts
    • Forms & Notices
  • Overview
  • Press Releases
  • SEC Filings
  • Stock Info
    • Stock Quote & Chart
    • Analyst Coverage
  • Events & Presentations
  • Governance
    • Governance Documents
    • Leadership
  • Resources
    • Investor FAQs
    • IR Contacts
    • Investor Alerts
    • Forms & Notices

Please note, that any opinions, estimates or forecasts regarding performance made by these analysts do not represent Aytu BioPharma or its management team. Aytu BioPharma is under no obligation to update this list, thus it may not be complete or up to date.

Firm Analyst
Maxim Group Naz Rahman
Aytu BioPharma Logo

Follow Us

Company

Overview

Our Mission, Vision, & Values

Leadership

Governance & Compliance

Partnering

Contact

Product

EXXUA™

ADHD Portfolio

Legacy Portfolio

Legal

Terms & Conditions

Privacy Policy

Contact

+1 (855) AYTU BIO
(+1 855-298-8246)

7900 East Union Avenue
Suite 920
Denver, Colorado

© 2025 · Aytu BioPharma · Powered by ACCESS Newswire

Share by: